One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P ® /Humate P ® treatment in von Willebrand disease patients-Reference-Cited by-同舟云学术

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P ® /Humate P ® treatment in von Willebrand disease patients

Published:2019-10-21 Issue:2 Volume:18 Page:295-305
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Jager Nico C. B.¹,Bukkems Laura H.¹^ORCID,Heijdra Jessica M.²^ORCID,Hazendonk Carolien H. C. A. M.²,Fijnvandraat Karin³,Meijer Karina⁴,Eikenboom Jeroen⁵^ORCID,Laros ‐ van Gorkom Britta A. P.⁶,Leebeek Frank W. G.⁷,Cnossen Marjon H.²,Mathôt Ron A. A.¹,Collins P. W.,Kruip M. J. H. A.,Polinder S.,Lock J.,van Moort I.,Goedhart M. C. H. J.,Coppens M.,Peters M.,Preijers T.,Brons P.,van der Meer F. J. M.,Schutgens R. E. G.,Fischer K.,Driessens M. H. E.,Zwaan C. M.,van Vliet I.,Liesner R.,Chowdary P.,Keeling D.,

Affiliation:

1. Hospital Pharmacy ‐ Clinical Pharmacology Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

2. Department of Paediatric Hematology Erasmus University Medical Center – Sophia Children's Hospital Rotterdam The Netherlands

3. Amsterdam UMC Emma Children's Hospital Pediatric Hematology University of Amsterdam Amsterdam Netherlands

4. Department of Haematology University Medical Center Groningen University of Groningen Groningen The Netherlands

5. Department of Internal Medicine Division of Thrombosis and Haemostasis Leiden University Medical Center Leiden The Netherlands

6. Department of Haematology Radboud University Medical Center Nijmegen The Netherlands

7. Department of Hematology Erasmus University Medical Center Rotterdam The Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14652

Reference33 articles.

1. Impact, Diagnosis and Treatment of von Willebrand Disease

2. Rapid discrimination of the phenotypic variants of von Willebrand disease

3. Von Willebrand’s Disease

4. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

5. Haemate P/Humate-P: a systematic review

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting von Willebrand disease: the current status and future directions of management therapies;Expert Review of Hematology;2023-10-12

2. Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3;Journal of Blood Medicine;2023-06

3. Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study;BMJ Open;2022-02

4. Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease;Blood Advances;2021-03-08

5. Perioperative management for patients with von Willebrand disease: Defining the optimal approach;European Journal of Haematology;2020-07-03